Is high minimal inhibitory concentration of vancomycin a predictor of poor response in MRSA infections?
Faulhaber
Gustavo
G
Zavascki
Alexandre
A
Fuchs
Sandra Costa
SC
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016470:Bacteremia / Q000188:drug therapy*; D002404:Catheterization / Q000009:adverse effects; D004334:Drug Administration Schedule; D006801:Humans; D016106:Methicillin Resistance; D016459:Prosthesis-Related Infections / Q000628:therapy; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013211:Staphylococcus aureus; D013997:Time Factors; D014640:Vancomycin / Q000008:administration & dosage* / Q000009:adverse effects
D000900:Anti-Bacterial Agents; D014640:Vancomycin